In the last trading session, 4.77 million Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares changed hands as the company’s beta touched 0.59. With the company’s per share price at $0.96 changed hands at $0.05 or 6.07% during last session, the market valuation stood at $106.23M. TLSA’s last price was a discount, traded about -81.25% off its 52-week high of $1.74. The share price had its 52-week low at $0.41, which suggests the last value was 57.29% up since then.

Analysts gave the Tiziana Life Sciences Ltd (TLSA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TLSA as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Tiziana Life Sciences Ltd’s EPS for the current quarter is expected to be 0.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information

Instantly TLSA was in green as seen at the end of in last trading. With action 9.13%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 37.89%, with the 5-day performance at 9.13% in the green. However, in the 30-day time frame, Tiziana Life Sciences Ltd (NASDAQ:TLSA) is 21.20% up.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -12.98%.

TLSA Dividends

Tiziana Life Sciences Ltd is expected to release its next quarterly earnings report in March.

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Nasdaq Composite Index ETF and Fidelity NASDAQ Composite Index Fund . With 167.84 shares estimated at $0.16 million under it, the former controlled 0.16% of total outstanding shares. On the other hand, Fidelity NASDAQ Composite Index Fund held about 0.07% of the shares, roughly 74.14 shares worth around $71177.0.